Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancer.
Hausmaninger H, Lehnert M, Steger G, Sevelda P, Michlmayr G, Hehenwarter W, Fridrik M, Samonigg H, Schiller L, Manfreda D, et al.
Hausmaninger H, et al. Among authors: hehenwarter w.
Onkologie. 1989 Oct;12(5):225-9. doi: 10.1159/000216651.
Onkologie. 1989.
PMID: 2685688
Clinical Trial.